Bayer Group Key Data

 

 

Q1 2017

 

Q1 2018

 

Change

 

Full Year 2017

 

 

€ million

 

€ million

 

%

 

€ million

2017 figures restated

1

For definition see Annual Report 2017, Chapter “Alternative Performance Measures Used by the Bayer Group.”

2

Employees calculated as full-time equivalents (FTEs)

Sales

 

9,680

 

9,138

 

−5.6

 

35,015

Change (adjusted for currency and portfolio effects)1

 

 

 

 

 

+2.0

 

+1.5%

Change in sales1

 

 

 

 

 

 

 

 

Volume

 

+4.5%

 

+3.2%

 

 

 

+2.3%

Price

 

+0.4%

 

−1.2%

 

 

 

−0.8%

Currency

 

+2.5%

 

−7.5%

 

 

 

−1.4%

Portfolio

 

+0.1%

 

−0.1%

 

 

 

+0.1%

EBITDA1

 

2,999

 

2,818

 

−6.0

 

8,563

Special items1

 

(55)

 

(78)

 

 

 

(725)

EBITDA before special items1

 

3,054

 

2,896

 

−5.2

 

9,288

EBITDA margin before special items1

 

31.5%

 

31.7%

 

 

 

26.5%

EBIT1

 

2,427

 

2,310

 

−4.8

 

5,903

Special items1

 

(102)

 

(78)

 

 

 

(1,227)

EBIT before special items1

 

2,529

 

2,388

 

−5.6

 

7,130

Financial result

 

(296)

 

130

 

.

 

(1,326)

Net income (from continuing and discontinued operations)

 

2,083

 

1,954

 

−6.2

 

7,336

Earnings per share1 from continuing and discontinued operations (€)

 

2.39

 

2.24

 

−6.3

 

8.41

Core earnings per share1 from continuing operations (€)

 

2.31

 

2.28

 

−1.3

 

6.74

Net cash provided by operating activities (from continuing and discontinued operations)

 

841

 

658

 

−21.8

 

8,134

Cash outflows for capital expenditures

 

415

 

349

 

−15.9

 

2,418

Research and development expenses

 

(1,094)

 

(1,040)

 

−4.9

 

4,504

Depreciation, amortization and impairments

 

572

 

508

 

−11.2

 

2,660

Number of employees at end of period2

 

99,860

 

100,110

 

+0.3

 

99,820

Personnel expenses (including pension expenses)

 

2,636

 

2,438

 

−7.5

 

9,528

Compare to Last Year